Computer Aided Effective Prediction of Complete Responders After Radiochemotherapy Based on Tumor Regression Grade Estimated by MR Imaging

The aim of this work is to implement an automatic method to predict and classify complete responders (CRs) patients, affected by rectal cancer and treated with neoadjuvant radiochemotherapy (RCT), by exploiting the tumor regression grade (MR-TRG) estimated by magnetic resonance imaging. For the purpose of the study, a total of 65 patients were enrolled and the magnetic resonance (MR) examinations to calculate TRG were performed using a 3.0 T scanner. By processing and testing patients’ data, the algorithm allows to determine the optimum threshold dividing CRs patients from patients that are considered non responders. The prediction accuracy of the classifier was investigated by using cross-validation statistical analysis in order to automatically determine the best testing rule. After collecting the outcomes of the performed cross-validation, the obtained results show the percentages of correct instances and misclassified patients. The automatic classification of CRs appears to be feasible and can be considered as a helpful method to predict CRs assisting clinicians to predict disease prognoses and patient survival prospects in order to provide treatments’ customization.

[1]  Silvia Conforto,et al.  Haralick’s texture features for the prediction of response to therapy in colorectal cancer: a preliminary study , 2018, La radiologia medica.

[2]  E E de Lange,et al.  Rectal carcinoma treated by preoperative irradiation: MR imaging and histopathologic correlation. , 1992, AJR. American journal of roentgenology.

[3]  Ivan Cecconello,et al.  Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer , 2016, Diseases of the colon and rectum.

[4]  H. Putter,et al.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. , 2001, The New England journal of medicine.

[5]  Rainer Fietkau,et al.  Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Stuart A. Taylor,et al.  Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting , 2018, European Radiology.

[7]  Karin Haustermans,et al.  Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  A. O'Grady,et al.  The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer , 2014, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[9]  Max Kuhn,et al.  Applied Predictive Modeling , 2013 .

[10]  Rainer Fietkau,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[11]  Damiano Caruso,et al.  Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer , 2017, Oncotarget.

[12]  Michael Fuchsjäger,et al.  Preoperative staging of rectal cancer. , 2003, European journal of radiology.

[13]  R. Vera,et al.  Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease‐free survival after preoperative radiochemotherapy for advanced rectal cancer , 2008, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[14]  Fábio Guilherme Campos,et al.  Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy: Long-term Results , 2004, Annals of surgery.

[15]  Sang Woo Lim,et al.  Coloproctology Clinical Significance of Tumor Regression Grade in Rectal Cancer with Preoperative Chemoradiotherapy , 2022 .

[16]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[17]  Antonio Esposito,et al.  A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  Silvia Conforto,et al.  Haralick's texture analysis applied to colorectal T2-weighted MRI: A preliminary study of significance for cancer evolution , 2017, 2017 13th IASTED International Conference on Biomedical Engineering (BioMed).

[19]  W Steinbrich,et al.  Recurrent rectal cancer: diagnosis with MR imaging versus CT. , 1988, Radiology.

[20]  L Påhlman,et al.  Improved survival with preoperative radiotherapy in resectable rectal cancer. , 1997, The New England journal of medicine.

[21]  Angelita Habr-Gama,et al.  Watch and Wait Approach Following Extended Neoadjuvant Chemoradiation for Distal Rectal Cancer: Are We Getting Closer to Anal Cancer Management? , 2013, Diseases of the colon and rectum.

[22]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[23]  Silvia Conforto,et al.  Segmenting MR Images by Level-Set Algorithms for Perspective Colorectal Cancer Diagnosis , 2017 .

[24]  Roberto Passariello,et al.  Preoperative staging of rectal cancer with MR Imaging: correlation with surgical and histopathologic findings. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.